Global Subcutaneous Biologics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Subcutaneous Biologics market size was valued at US$ million in 2023. With growing demand in downstream market, the Subcutaneous Biologics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Subcutaneous Biologics market. Subcutaneous Biologics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Subcutaneous Biologics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Subcutaneous Biologics market.
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
Key Features:
The report on Subcutaneous Biologics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Subcutaneous Biologics market. It may include historical data, market segmentation by Type (e.g., Syringe, Wearable injector), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Subcutaneous Biologics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Subcutaneous Biologics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Subcutaneous Biologics industry. This include advancements in Subcutaneous Biologics technology, Subcutaneous Biologics new entrants, Subcutaneous Biologics new investment, and other innovations that are shaping the future of Subcutaneous Biologics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Subcutaneous Biologics market. It includes factors influencing customer ' purchasing decisions, preferences for Subcutaneous Biologics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Subcutaneous Biologics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Subcutaneous Biologics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Subcutaneous Biologics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Subcutaneous Biologics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Subcutaneous Biologics market.
Market Segmentation:
Subcutaneous Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Subcutaneous Biologics market size was valued at US$ million in 2023. With growing demand in downstream market, the Subcutaneous Biologics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Subcutaneous Biologics market. Subcutaneous Biologics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Subcutaneous Biologics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Subcutaneous Biologics market.
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
Key Features:
The report on Subcutaneous Biologics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Subcutaneous Biologics market. It may include historical data, market segmentation by Type (e.g., Syringe, Wearable injector), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Subcutaneous Biologics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Subcutaneous Biologics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Subcutaneous Biologics industry. This include advancements in Subcutaneous Biologics technology, Subcutaneous Biologics new entrants, Subcutaneous Biologics new investment, and other innovations that are shaping the future of Subcutaneous Biologics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Subcutaneous Biologics market. It includes factors influencing customer ' purchasing decisions, preferences for Subcutaneous Biologics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Subcutaneous Biologics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Subcutaneous Biologics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Subcutaneous Biologics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Subcutaneous Biologics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Subcutaneous Biologics market.
Market Segmentation:
Subcutaneous Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Syringe
- Wearable injector
- Automatic injector
- Implants
- Hospital pharmacies
- Retail pharmacies
- Drug stores
- Online pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Pfizer Inc.
- Genentech Inc.
- Novartis AG
- Biogen Idec
- AbbVie Inc.
- F. Hoffmann-La Roche AG
- Bristol-Myers Squibb
- Eisai Inc.
- Takeda Pharmaceuticals Ltd.
- Alnylam Pharmaceuticals
- Bayer AG
- GlaxoSmithKline
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Biologics Market Size 2019-2030
2.1.2 Subcutaneous Biologics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Subcutaneous Biologics Segment by Type
2.2.1 Syringe
2.2.2 Wearable injector
2.2.3 Automatic injector
2.2.4 Implants
2.3 Subcutaneous Biologics Market Size by Type
2.3.1 Subcutaneous Biologics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
2.4 Subcutaneous Biologics Segment by Application
2.4.1 Hospital pharmacies
2.4.2 Retail pharmacies
2.4.3 Drug stores
2.4.4 Online pharmacies
2.5 Subcutaneous Biologics Market Size by Application
2.5.1 Subcutaneous Biologics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
3 SUBCUTANEOUS BIOLOGICS MARKET SIZE BY PLAYER
3.1 Subcutaneous Biologics Market Size Market Share by Players
3.1.1 Global Subcutaneous Biologics Revenue by Players (2019-2024)
3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2019-2024)
3.2 Global Subcutaneous Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SUBCUTANEOUS BIOLOGICS BY REGIONS
4.1 Subcutaneous Biologics Market Size by Regions (2019-2024)
4.2 Americas Subcutaneous Biologics Market Size Growth (2019-2024)
4.3 APAC Subcutaneous Biologics Market Size Growth (2019-2024)
4.4 Europe Subcutaneous Biologics Market Size Growth (2019-2024)
4.5 Middle East & Africa Subcutaneous Biologics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Subcutaneous Biologics Market Size by Country (2019-2024)
5.2 Americas Subcutaneous Biologics Market Size by Type (2019-2024)
5.3 Americas Subcutaneous Biologics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Biologics Market Size by Region (2019-2024)
6.2 APAC Subcutaneous Biologics Market Size by Type (2019-2024)
6.3 APAC Subcutaneous Biologics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Subcutaneous Biologics by Country (2019-2024)
7.2 Europe Subcutaneous Biologics Market Size by Type (2019-2024)
7.3 Europe Subcutaneous Biologics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Biologics by Region (2019-2024)
8.2 Middle East & Africa Subcutaneous Biologics Market Size by Type (2019-2024)
8.3 Middle East & Africa Subcutaneous Biologics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SUBCUTANEOUS BIOLOGICS MARKET FORECAST
10.1 Global Subcutaneous Biologics Forecast by Regions (2025-2030)
10.1.1 Global Subcutaneous Biologics Forecast by Regions (2025-2030)
10.1.2 Americas Subcutaneous Biologics Forecast
10.1.3 APAC Subcutaneous Biologics Forecast
10.1.4 Europe Subcutaneous Biologics Forecast
10.1.5 Middle East & Africa Subcutaneous Biologics Forecast
10.2 Americas Subcutaneous Biologics Forecast by Country (2025-2030)
10.2.1 United States Subcutaneous Biologics Market Forecast
10.2.2 Canada Subcutaneous Biologics Market Forecast
10.2.3 Mexico Subcutaneous Biologics Market Forecast
10.2.4 Brazil Subcutaneous Biologics Market Forecast
10.3 APAC Subcutaneous Biologics Forecast by Region (2025-2030)
10.3.1 China Subcutaneous Biologics Market Forecast
10.3.2 Japan Subcutaneous Biologics Market Forecast
10.3.3 Korea Subcutaneous Biologics Market Forecast
10.3.4 Southeast Asia Subcutaneous Biologics Market Forecast
10.3.5 India Subcutaneous Biologics Market Forecast
10.3.6 Australia Subcutaneous Biologics Market Forecast
10.4 Europe Subcutaneous Biologics Forecast by Country (2025-2030)
10.4.1 Germany Subcutaneous Biologics Market Forecast
10.4.2 France Subcutaneous Biologics Market Forecast
10.4.3 UK Subcutaneous Biologics Market Forecast
10.4.4 Italy Subcutaneous Biologics Market Forecast
10.4.5 Russia Subcutaneous Biologics Market Forecast
10.5 Middle East & Africa Subcutaneous Biologics Forecast by Region (2025-2030)
10.5.1 Egypt Subcutaneous Biologics Market Forecast
10.5.2 South Africa Subcutaneous Biologics Market Forecast
10.5.3 Israel Subcutaneous Biologics Market Forecast
10.5.4 Turkey Subcutaneous Biologics Market Forecast
10.5.5 GCC Countries Subcutaneous Biologics Market Forecast
10.6 Global Subcutaneous Biologics Forecast by Type (2025-2030)
10.7 Global Subcutaneous Biologics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Subcutaneous Biologics Product Offered
11.1.3 Abbott Laboratories Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Information
11.2.2 Pfizer Inc. Subcutaneous Biologics Product Offered
11.2.3 Pfizer Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc. Main Business Overview
11.2.5 Pfizer Inc. Latest Developments
11.3 Genentech Inc.
11.3.1 Genentech Inc. Company Information
11.3.2 Genentech Inc. Subcutaneous Biologics Product Offered
11.3.3 Genentech Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Genentech Inc. Main Business Overview
11.3.5 Genentech Inc. Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Subcutaneous Biologics Product Offered
11.4.3 Novartis AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Biogen Idec
11.5.1 Biogen Idec Company Information
11.5.2 Biogen Idec Subcutaneous Biologics Product Offered
11.5.3 Biogen Idec Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Biogen Idec Main Business Overview
11.5.5 Biogen Idec Latest Developments
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Information
11.6.2 AbbVie Inc. Subcutaneous Biologics Product Offered
11.6.3 AbbVie Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AbbVie Inc. Main Business Overview
11.6.5 AbbVie Inc. Latest Developments
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Information
11.7.2 F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offered
11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 F. Hoffmann-La Roche AG Main Business Overview
11.7.5 F. Hoffmann-La Roche AG Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Subcutaneous Biologics Product Offered
11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 Eisai Inc.
11.9.1 Eisai Inc. Company Information
11.9.2 Eisai Inc. Subcutaneous Biologics Product Offered
11.9.3 Eisai Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eisai Inc. Main Business Overview
11.9.5 Eisai Inc. Latest Developments
11.10 Takeda Pharmaceuticals Ltd.
11.10.1 Takeda Pharmaceuticals Ltd. Company Information
11.10.2 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offered
11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Pharmaceuticals Ltd. Main Business Overview
11.10.5 Takeda Pharmaceuticals Ltd. Latest Developments
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Information
11.11.2 Alnylam Pharmaceuticals Subcutaneous Biologics Product Offered
11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Alnylam Pharmaceuticals Main Business Overview
11.11.5 Alnylam Pharmaceuticals Latest Developments
11.12 Bayer AG
11.12.1 Bayer AG Company Information
11.12.2 Bayer AG Subcutaneous Biologics Product Offered
11.12.3 Bayer AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bayer AG Main Business Overview
11.12.5 Bayer AG Latest Developments
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Information
11.13.2 GlaxoSmithKline Subcutaneous Biologics Product Offered
11.13.3 GlaxoSmithKline Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 GlaxoSmithKline Main Business Overview
11.13.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Biologics Market Size 2019-2030
2.1.2 Subcutaneous Biologics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Subcutaneous Biologics Segment by Type
2.2.1 Syringe
2.2.2 Wearable injector
2.2.3 Automatic injector
2.2.4 Implants
2.3 Subcutaneous Biologics Market Size by Type
2.3.1 Subcutaneous Biologics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
2.4 Subcutaneous Biologics Segment by Application
2.4.1 Hospital pharmacies
2.4.2 Retail pharmacies
2.4.3 Drug stores
2.4.4 Online pharmacies
2.5 Subcutaneous Biologics Market Size by Application
2.5.1 Subcutaneous Biologics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
3 SUBCUTANEOUS BIOLOGICS MARKET SIZE BY PLAYER
3.1 Subcutaneous Biologics Market Size Market Share by Players
3.1.1 Global Subcutaneous Biologics Revenue by Players (2019-2024)
3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2019-2024)
3.2 Global Subcutaneous Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SUBCUTANEOUS BIOLOGICS BY REGIONS
4.1 Subcutaneous Biologics Market Size by Regions (2019-2024)
4.2 Americas Subcutaneous Biologics Market Size Growth (2019-2024)
4.3 APAC Subcutaneous Biologics Market Size Growth (2019-2024)
4.4 Europe Subcutaneous Biologics Market Size Growth (2019-2024)
4.5 Middle East & Africa Subcutaneous Biologics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Subcutaneous Biologics Market Size by Country (2019-2024)
5.2 Americas Subcutaneous Biologics Market Size by Type (2019-2024)
5.3 Americas Subcutaneous Biologics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Biologics Market Size by Region (2019-2024)
6.2 APAC Subcutaneous Biologics Market Size by Type (2019-2024)
6.3 APAC Subcutaneous Biologics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Subcutaneous Biologics by Country (2019-2024)
7.2 Europe Subcutaneous Biologics Market Size by Type (2019-2024)
7.3 Europe Subcutaneous Biologics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Biologics by Region (2019-2024)
8.2 Middle East & Africa Subcutaneous Biologics Market Size by Type (2019-2024)
8.3 Middle East & Africa Subcutaneous Biologics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SUBCUTANEOUS BIOLOGICS MARKET FORECAST
10.1 Global Subcutaneous Biologics Forecast by Regions (2025-2030)
10.1.1 Global Subcutaneous Biologics Forecast by Regions (2025-2030)
10.1.2 Americas Subcutaneous Biologics Forecast
10.1.3 APAC Subcutaneous Biologics Forecast
10.1.4 Europe Subcutaneous Biologics Forecast
10.1.5 Middle East & Africa Subcutaneous Biologics Forecast
10.2 Americas Subcutaneous Biologics Forecast by Country (2025-2030)
10.2.1 United States Subcutaneous Biologics Market Forecast
10.2.2 Canada Subcutaneous Biologics Market Forecast
10.2.3 Mexico Subcutaneous Biologics Market Forecast
10.2.4 Brazil Subcutaneous Biologics Market Forecast
10.3 APAC Subcutaneous Biologics Forecast by Region (2025-2030)
10.3.1 China Subcutaneous Biologics Market Forecast
10.3.2 Japan Subcutaneous Biologics Market Forecast
10.3.3 Korea Subcutaneous Biologics Market Forecast
10.3.4 Southeast Asia Subcutaneous Biologics Market Forecast
10.3.5 India Subcutaneous Biologics Market Forecast
10.3.6 Australia Subcutaneous Biologics Market Forecast
10.4 Europe Subcutaneous Biologics Forecast by Country (2025-2030)
10.4.1 Germany Subcutaneous Biologics Market Forecast
10.4.2 France Subcutaneous Biologics Market Forecast
10.4.3 UK Subcutaneous Biologics Market Forecast
10.4.4 Italy Subcutaneous Biologics Market Forecast
10.4.5 Russia Subcutaneous Biologics Market Forecast
10.5 Middle East & Africa Subcutaneous Biologics Forecast by Region (2025-2030)
10.5.1 Egypt Subcutaneous Biologics Market Forecast
10.5.2 South Africa Subcutaneous Biologics Market Forecast
10.5.3 Israel Subcutaneous Biologics Market Forecast
10.5.4 Turkey Subcutaneous Biologics Market Forecast
10.5.5 GCC Countries Subcutaneous Biologics Market Forecast
10.6 Global Subcutaneous Biologics Forecast by Type (2025-2030)
10.7 Global Subcutaneous Biologics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Subcutaneous Biologics Product Offered
11.1.3 Abbott Laboratories Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Information
11.2.2 Pfizer Inc. Subcutaneous Biologics Product Offered
11.2.3 Pfizer Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc. Main Business Overview
11.2.5 Pfizer Inc. Latest Developments
11.3 Genentech Inc.
11.3.1 Genentech Inc. Company Information
11.3.2 Genentech Inc. Subcutaneous Biologics Product Offered
11.3.3 Genentech Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Genentech Inc. Main Business Overview
11.3.5 Genentech Inc. Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Subcutaneous Biologics Product Offered
11.4.3 Novartis AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Biogen Idec
11.5.1 Biogen Idec Company Information
11.5.2 Biogen Idec Subcutaneous Biologics Product Offered
11.5.3 Biogen Idec Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Biogen Idec Main Business Overview
11.5.5 Biogen Idec Latest Developments
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Information
11.6.2 AbbVie Inc. Subcutaneous Biologics Product Offered
11.6.3 AbbVie Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AbbVie Inc. Main Business Overview
11.6.5 AbbVie Inc. Latest Developments
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Information
11.7.2 F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offered
11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 F. Hoffmann-La Roche AG Main Business Overview
11.7.5 F. Hoffmann-La Roche AG Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Subcutaneous Biologics Product Offered
11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 Eisai Inc.
11.9.1 Eisai Inc. Company Information
11.9.2 Eisai Inc. Subcutaneous Biologics Product Offered
11.9.3 Eisai Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eisai Inc. Main Business Overview
11.9.5 Eisai Inc. Latest Developments
11.10 Takeda Pharmaceuticals Ltd.
11.10.1 Takeda Pharmaceuticals Ltd. Company Information
11.10.2 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offered
11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Pharmaceuticals Ltd. Main Business Overview
11.10.5 Takeda Pharmaceuticals Ltd. Latest Developments
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Information
11.11.2 Alnylam Pharmaceuticals Subcutaneous Biologics Product Offered
11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Alnylam Pharmaceuticals Main Business Overview
11.11.5 Alnylam Pharmaceuticals Latest Developments
11.12 Bayer AG
11.12.1 Bayer AG Company Information
11.12.2 Bayer AG Subcutaneous Biologics Product Offered
11.12.3 Bayer AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bayer AG Main Business Overview
11.12.5 Bayer AG Latest Developments
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Information
11.13.2 GlaxoSmithKline Subcutaneous Biologics Product Offered
11.13.3 GlaxoSmithKline Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 GlaxoSmithKline Main Business Overview
11.13.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Subcutaneous Biologics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Syringe
Table 3. Major Players of Wearable injector
Table 4. Major Players of Automatic injector
Table 5. Major Players of Implants
Table 6. Subcutaneous Biologics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 9. Subcutaneous Biologics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 12. Global Subcutaneous Biologics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Subcutaneous Biologics Revenue Market Share by Player (2019-2024)
Table 14. Subcutaneous Biologics Key Players Head office and Products Offered
Table 15. Subcutaneous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Subcutaneous Biologics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Subcutaneous Biologics Market Size Market Share by Regions (2019-2024)
Table 20. Global Subcutaneous Biologics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Subcutaneous Biologics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Subcutaneous Biologics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Subcutaneous Biologics Market Size Market Share by Country (2019-2024)
Table 24. Americas Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 26. Americas Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 28. APAC Subcutaneous Biologics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Subcutaneous Biologics Market Size Market Share by Region (2019-2024)
Table 30. APAC Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 32. APAC Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 34. Europe Subcutaneous Biologics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Subcutaneous Biologics Market Size Market Share by Country (2019-2024)
Table 36. Europe Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 38. Europe Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Subcutaneous Biologics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Subcutaneous Biologics
Table 47. Key Market Challenges & Risks of Subcutaneous Biologics
Table 48. Key Industry Trends of Subcutaneous Biologics
Table 49. Global Subcutaneous Biologics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Subcutaneous Biologics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Subcutaneous Biologics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Subcutaneous Biologics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 54. Abbott Laboratories Subcutaneous Biologics Product Offered
Table 55. Abbott Laboratories Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Pfizer Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 59. Pfizer Inc. Subcutaneous Biologics Product Offered
Table 60. Pfizer Inc. Main Business
Table 61. Pfizer Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Pfizer Inc. Latest Developments
Table 63. Genentech Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 64. Genentech Inc. Subcutaneous Biologics Product Offered
Table 65. Genentech Inc. Main Business
Table 66. Genentech Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Genentech Inc. Latest Developments
Table 68. Novartis AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 69. Novartis AG Subcutaneous Biologics Product Offered
Table 70. Novartis AG Main Business
Table 71. Novartis AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Novartis AG Latest Developments
Table 73. Biogen Idec Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 74. Biogen Idec Subcutaneous Biologics Product Offered
Table 75. Biogen Idec Main Business
Table 76. Biogen Idec Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Biogen Idec Latest Developments
Table 78. AbbVie Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 79. AbbVie Inc. Subcutaneous Biologics Product Offered
Table 80. AbbVie Inc. Main Business
Table 81. AbbVie Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. AbbVie Inc. Latest Developments
Table 83. F. Hoffmann-La Roche AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 84. F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offered
Table 85. F. Hoffmann-La Roche AG Main Business
Table 86. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. F. Hoffmann-La Roche AG Latest Developments
Table 88. Bristol-Myers Squibb Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 89. Bristol-Myers Squibb Subcutaneous Biologics Product Offered
Table 90. Bristol-Myers Squibb Main Business
Table 91. Bristol-Myers Squibb Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Bristol-Myers Squibb Latest Developments
Table 93. Eisai Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 94. Eisai Inc. Subcutaneous Biologics Product Offered
Table 95. Eisai Inc. Main Business
Table 96. Eisai Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Eisai Inc. Latest Developments
Table 98. Takeda Pharmaceuticals Ltd. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 99. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offered
Table 100. Takeda Pharmaceuticals Ltd. Main Business
Table 101. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Takeda Pharmaceuticals Ltd. Latest Developments
Table 103. Alnylam Pharmaceuticals Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 104. Alnylam Pharmaceuticals Subcutaneous Biologics Product Offered
Table 105. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Alnylam Pharmaceuticals Main Business
Table 107. Alnylam Pharmaceuticals Latest Developments
Table 108. Bayer AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 109. Bayer AG Subcutaneous Biologics Product Offered
Table 110. Bayer AG Main Business
Table 111. Bayer AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Bayer AG Latest Developments
Table 113. GlaxoSmithKline Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 114. GlaxoSmithKline Subcutaneous Biologics Product Offered
Table 115. GlaxoSmithKline Main Business
Table 116. GlaxoSmithKline Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. GlaxoSmithKline Latest Developments
Table 1. Subcutaneous Biologics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Syringe
Table 3. Major Players of Wearable injector
Table 4. Major Players of Automatic injector
Table 5. Major Players of Implants
Table 6. Subcutaneous Biologics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 9. Subcutaneous Biologics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 12. Global Subcutaneous Biologics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Subcutaneous Biologics Revenue Market Share by Player (2019-2024)
Table 14. Subcutaneous Biologics Key Players Head office and Products Offered
Table 15. Subcutaneous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Subcutaneous Biologics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Subcutaneous Biologics Market Size Market Share by Regions (2019-2024)
Table 20. Global Subcutaneous Biologics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Subcutaneous Biologics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Subcutaneous Biologics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Subcutaneous Biologics Market Size Market Share by Country (2019-2024)
Table 24. Americas Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 26. Americas Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 28. APAC Subcutaneous Biologics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Subcutaneous Biologics Market Size Market Share by Region (2019-2024)
Table 30. APAC Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 32. APAC Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 34. Europe Subcutaneous Biologics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Subcutaneous Biologics Market Size Market Share by Country (2019-2024)
Table 36. Europe Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 38. Europe Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Subcutaneous Biologics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Subcutaneous Biologics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Subcutaneous Biologics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Subcutaneous Biologics
Table 47. Key Market Challenges & Risks of Subcutaneous Biologics
Table 48. Key Industry Trends of Subcutaneous Biologics
Table 49. Global Subcutaneous Biologics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Subcutaneous Biologics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Subcutaneous Biologics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Subcutaneous Biologics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 54. Abbott Laboratories Subcutaneous Biologics Product Offered
Table 55. Abbott Laboratories Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Pfizer Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 59. Pfizer Inc. Subcutaneous Biologics Product Offered
Table 60. Pfizer Inc. Main Business
Table 61. Pfizer Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Pfizer Inc. Latest Developments
Table 63. Genentech Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 64. Genentech Inc. Subcutaneous Biologics Product Offered
Table 65. Genentech Inc. Main Business
Table 66. Genentech Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Genentech Inc. Latest Developments
Table 68. Novartis AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 69. Novartis AG Subcutaneous Biologics Product Offered
Table 70. Novartis AG Main Business
Table 71. Novartis AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Novartis AG Latest Developments
Table 73. Biogen Idec Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 74. Biogen Idec Subcutaneous Biologics Product Offered
Table 75. Biogen Idec Main Business
Table 76. Biogen Idec Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Biogen Idec Latest Developments
Table 78. AbbVie Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 79. AbbVie Inc. Subcutaneous Biologics Product Offered
Table 80. AbbVie Inc. Main Business
Table 81. AbbVie Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. AbbVie Inc. Latest Developments
Table 83. F. Hoffmann-La Roche AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 84. F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offered
Table 85. F. Hoffmann-La Roche AG Main Business
Table 86. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. F. Hoffmann-La Roche AG Latest Developments
Table 88. Bristol-Myers Squibb Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 89. Bristol-Myers Squibb Subcutaneous Biologics Product Offered
Table 90. Bristol-Myers Squibb Main Business
Table 91. Bristol-Myers Squibb Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Bristol-Myers Squibb Latest Developments
Table 93. Eisai Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 94. Eisai Inc. Subcutaneous Biologics Product Offered
Table 95. Eisai Inc. Main Business
Table 96. Eisai Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Eisai Inc. Latest Developments
Table 98. Takeda Pharmaceuticals Ltd. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 99. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offered
Table 100. Takeda Pharmaceuticals Ltd. Main Business
Table 101. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Takeda Pharmaceuticals Ltd. Latest Developments
Table 103. Alnylam Pharmaceuticals Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 104. Alnylam Pharmaceuticals Subcutaneous Biologics Product Offered
Table 105. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Alnylam Pharmaceuticals Main Business
Table 107. Alnylam Pharmaceuticals Latest Developments
Table 108. Bayer AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 109. Bayer AG Subcutaneous Biologics Product Offered
Table 110. Bayer AG Main Business
Table 111. Bayer AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Bayer AG Latest Developments
Table 113. GlaxoSmithKline Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors
Table 114. GlaxoSmithKline Subcutaneous Biologics Product Offered
Table 115. GlaxoSmithKline Main Business
Table 116. GlaxoSmithKline Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Subcutaneous Biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Subcutaneous Biologics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Subcutaneous Biologics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Subcutaneous Biologics Sales Market Share by Country/Region (2023)
Figure 8. Subcutaneous Biologics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Subcutaneous Biologics Market Size Market Share by Type in 2023
Figure 10. Subcutaneous Biologics in Hospital pharmacies
Figure 11. Global Subcutaneous Biologics Market: Hospital pharmacies (2019-2024) & ($ Millions)
Figure 12. Subcutaneous Biologics in Retail pharmacies
Figure 13. Global Subcutaneous Biologics Market: Retail pharmacies (2019-2024) & ($ Millions)
Figure 14. Subcutaneous Biologics in Drug stores
Figure 15. Global Subcutaneous Biologics Market: Drug stores (2019-2024) & ($ Millions)
Figure 16. Subcutaneous Biologics in Online pharmacies
Figure 17. Global Subcutaneous Biologics Market: Online pharmacies (2019-2024) & ($ Millions)
Figure 18. Global Subcutaneous Biologics Market Size Market Share by Application in 2023
Figure 19. Global Subcutaneous Biologics Revenue Market Share by Player in 2023
Figure 20. Global Subcutaneous Biologics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 22. APAC Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 23. Europe Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 25. Americas Subcutaneous Biologics Value Market Share by Country in 2023
Figure 26. United States Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Subcutaneous Biologics Market Size Market Share by Region in 2023
Figure 31. APAC Subcutaneous Biologics Market Size Market Share by Type in 2023
Figure 32. APAC Subcutaneous Biologics Market Size Market Share by Application in 2023
Figure 33. China Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Subcutaneous Biologics Market Size Market Share by Country in 2023
Figure 40. Europe Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 56. APAC Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 57. Europe Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 59. United States Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 60. Canada Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 63. China Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 64. Japan Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 65. Korea Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 67. India Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 68. Australia Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 69. Germany Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 70. France Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 71. UK Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 72. Italy Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 73. Russia Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 74. Spain Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 77. Israel Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 80. Global Subcutaneous Biologics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Subcutaneous Biologics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Subcutaneous Biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Subcutaneous Biologics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Subcutaneous Biologics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Subcutaneous Biologics Sales Market Share by Country/Region (2023)
Figure 8. Subcutaneous Biologics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Subcutaneous Biologics Market Size Market Share by Type in 2023
Figure 10. Subcutaneous Biologics in Hospital pharmacies
Figure 11. Global Subcutaneous Biologics Market: Hospital pharmacies (2019-2024) & ($ Millions)
Figure 12. Subcutaneous Biologics in Retail pharmacies
Figure 13. Global Subcutaneous Biologics Market: Retail pharmacies (2019-2024) & ($ Millions)
Figure 14. Subcutaneous Biologics in Drug stores
Figure 15. Global Subcutaneous Biologics Market: Drug stores (2019-2024) & ($ Millions)
Figure 16. Subcutaneous Biologics in Online pharmacies
Figure 17. Global Subcutaneous Biologics Market: Online pharmacies (2019-2024) & ($ Millions)
Figure 18. Global Subcutaneous Biologics Market Size Market Share by Application in 2023
Figure 19. Global Subcutaneous Biologics Revenue Market Share by Player in 2023
Figure 20. Global Subcutaneous Biologics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 22. APAC Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 23. Europe Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Subcutaneous Biologics Market Size 2019-2024 ($ Millions)
Figure 25. Americas Subcutaneous Biologics Value Market Share by Country in 2023
Figure 26. United States Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Subcutaneous Biologics Market Size Market Share by Region in 2023
Figure 31. APAC Subcutaneous Biologics Market Size Market Share by Type in 2023
Figure 32. APAC Subcutaneous Biologics Market Size Market Share by Application in 2023
Figure 33. China Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Subcutaneous Biologics Market Size Market Share by Country in 2023
Figure 40. Europe Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Subcutaneous Biologics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 56. APAC Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 57. Europe Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 59. United States Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 60. Canada Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 63. China Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 64. Japan Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 65. Korea Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 67. India Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 68. Australia Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 69. Germany Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 70. France Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 71. UK Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 72. Italy Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 73. Russia Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 74. Spain Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 77. Israel Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Subcutaneous Biologics Market Size 2025-2030 ($ Millions)
Figure 80. Global Subcutaneous Biologics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Subcutaneous Biologics Market Size Market Share Forecast by Application (2025-2030)
